scalebrown5
About
Selinexor, the selective chemical of nuclear move, increases the anti-tumor action regarding olaparib in double negative breast cancers regardless of BRCA1 mutation position.
Selinexor, the selective chemical of nuclear move, increases the anti-tumor action regarding olaparib in double negative breast cancers regardless of BRCA1 mutation position.